Nanoparticles that turn inflammation into propulsion power deliver targeted IBD treatment, enhancing precision and efficacy.
Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...
Mirikizumab, a drug currently approved by the Food and Drug Administration (FDA) for the treatment of ulcerative colitis, ...
Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...
Abu Dhabi, UAE: Sheikh Shakhbout Medical City (SSMC), one of the UAE’s largest hospitals for serious and complex care and a ...
Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients ...
Not everyone responds equally well to treatments for inflammatory bowel disease (IBD). What will work for individual patients involves trial and error during the treatment process.
Yes, kidney stones can cause gastrointestinal (GI) problems, such as bloating, diarrhea, and constipation. This article ...
P13, a biosimilar of infliximab, in inflammatory bowel diseases: a systematic review and meta-analysis," published in the November 2024 issue of Gastroenterology by Hu et al. Since 2015, CT-P13, a ...
Adult diabetes cases worldwide have more than quadrupled, according to a new analysis from The Lancet journal.